TLR2 and Chédiak-Higashi syndrome: In these in vitro studies of skin fibroblasts obtained from individuals with CHS, we demonstrate hyperactive inflammatory immune activity at baseline, yet hyporesponsiveness to immunogenic LPS challenge, potentially due to the reduced expression and disturbed trafficking of TLR-2 and −4.